Maureen J. Guichelaar

Delft, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Information Deficits, Information Needs, and Preferences Regarding eHealth in a Dutch Population With Metabolic Dysfunction-Associated Steatotic Liver Disease: Cross-Sectional Survey Study.

Information Deficits, Information Needs, and Preferences Regarding eHealth in a Dutch Population With Metabolic Dysfunction-Associated Steatotic Liver Disease: Cross-Sectional Survey Study.

Journal: JMIR formative research

Published: June 04, 2025

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.

Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.

Journal: Trials

Published: October 04, 2023

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.

An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.

Journal: Journal of hepatology

Published: July 19, 2023

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.

Journal: Trials

Published: June 01, 2022

Three cases of hepatocellular carcinoma in Fontan patients: Review of the literature and suggestions for hepatic screening.

Three cases of hepatocellular carcinoma in Fontan patients: Review of the literature and suggestions for hepatic screening.

Journal: International journal of cardiology

Published: December 16, 2015

HLA-DRB103:01 and HLA-DRB104:01 modify the presentation and outcome in autoimmune hepatitis type-1.

HLA-DRB103:01 and HLA-DRB104:01 modify the presentation and outcome in autoimmune hepatitis type-1.

Journal: Genes and immunity

Published: October 15, 2014

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.

Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.

Journal: Scandinavian journal of gastroenterology

Published: August 16, 2014

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.

Journal: Gastroenterology

Published: December 19, 2013

Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease?

Decreased muscle mass in nonalcoholic fatty liver disease: new evidence of a link between growth hormone and fatty liver disease?

Journal: Hepatology (Baltimore, Md.)

Published: October 23, 2013

Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis.

Cytotoxic T lymphocyte antigen-4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 15, 2012

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.

Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.

Journal: Journal of hepatology

Published: April 03, 2012

Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.

Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.

Journal: Obesity (Silver Spring, Md.)

Published: October 14, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026